The Selank/Semax Blend combines two synthetic heptapeptides, Selank, a tuftsin analog, and Semax, an ACTH(4-10) analog, in a single vial for research teams that want to study both neuroactive peptides in parallel. Each compound carries its own well-characterized preclinical literature, and the blend format supports comparative and combined-exposure experimental designs. Puritide Research supplies this blend as a high-purity, research-use-only material, synthesized for in vitro and animal-model work and backed by third-party-verified certificates of analysis so your data rests on consistent, documented quality.
Available Sizes
- ›Selank/Semax Blend 10mg (5+5) Vial
- ›Selank/Semax Blend 20mg (10+10) Vial
Product Specifications
- Application
- Combined neuropeptide, anxiolytic, and neuroprotective pathway research
- Appearance
- Solid, white lyophilized powder in a sealed glass vial
- Chemical Formula
- Selank: C33H57N11O9 / Semax: C37H51N9O10S
- CAS Number
- Selank: 129954-34-3 / Semax: 80714-61-0
- Molecular Weight
- Selank: ~751.88 g/mol / Semax: ~813.93 g/mol
- Synonyms
- Selank (TP-7, tuftsin analog, TKPRPGP) + Semax (ACTH(4-10) analog, MEHFPGP)
- Storage
- Store at ≤25°C, sealed, away from heat, light, and moisture. For extended storage, keep lyophilized and refrigerated or frozen.
What Is the Selank/Semax Blend?
The Selank/Semax Blend is a co-formulated preparation of two distinct synthetic heptapeptides supplied in a defined ratio (5+5 or 10+10). Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a stabilized analog of the tuftsin tetrapeptide, and Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is an analog of the ACTH(4-10) fragment. Both were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and share a Pro-Gly-Pro C-terminal motif associated with enzymatic stability.
In experimental settings, the blend is studied to examine the two peptides in combination, for instance, comparing anxiolytic-related signaling associated with Selank against neurotrophic and neuroprotective signaling associated with Semax within the same model system. This supports combined-exposure and comparative research designs.
Present understanding of each component derives from in vitro assays and animal models, together with clinical research conducted primarily in Russia. Findings should be interpreted within their experimental context and not treated as established outcomes. Puritide Research supplies this blend strictly for laboratory use; it is not approved for human or veterinary application.
Puritide Research supplies Selank/Semax Blend strictly for laboratory research use. Not for human or veterinary use.
Research Use Only
